LPCAT2 and cPLA2 were increased by up to 3‐fold in NASH compared with NAFL, whereas ALOX15 was significantly increased by up to 6‐fold. This evidence concerns the gene LPCAT2 and metabolic dysfunction-associated steatohepatitis.